Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Cotinga Pharmaceuticals Inc COTQF

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up to 30% of all cancers.


GREY:COTQF - Post by User

Bullboard Posts
Post by ErickSodhion May 04, 2004 9:17am
185 Views
Post# 7437665

Definitely Halted

Definitely HaltedFrom https://www.cdnx.com/data/lcdb/DOCP/MAY2004/RPWP01%21%2EDOC Source MARKET NEWS Date 05/03/2004 Time 01:43:50 PM Company Conac Software Corporation Title Sustaining Fees Halt DMIS Processed No CDNX Symbol: COT Exchange: VSE Symbol: COT Exchange: Symbol: Exchange: Symbol: Press Release [200/News Release] COT V CONAC SOFTWARE CORP MAY 03 2004 13:41 PM Sustaining Fees Halt --->@NEWS RELEASE TSX VENTURE EXCHANGE ("ZTSX-TV") MARKET REGULATION SERVICES INC ("ZTSXMR-TV") - Sustaining Fees-Halt Further to TSX Venture Exchange Notice to Issuers Bulletin of April 8, 2004 announcing the due date for payment of outstanding sustaining fees, as of April 30, 2004, the Exchange has not received payment from the following trading issuers of their annual sustaining fees. A copy of the April 8, 2004 Bulletin is posted in the News section of the home page of the Exchange website at www.tsx.com. At the open of business on Tuesday, May 4, 2004, the securities of these issuers will be halted from trading for failure to pay their annual sustaining fees. In addition, an issuer halted for failure to pay the sustaining fee will be subject to a processing fee of $250.00 + GST to be brought back to trade. If payment is not made within 10 business days of being halted, the issuer will be suspended from trading without further notice. Once an issuer is suspended from trading, it will be subject to a reinstatement review, which must be accompanied by the applicable fee of $500.00 + GST. In May 2004, suspended issuers should expect to be sent a notice to delist. If issuers have any questions regarding this halt, please contact: Joanne Butz, Manager Compliance & Disclosure, Phone 403-218-2820 Fax 403-237-0450 Symbol Issuer Name ANI Anitech Enterprises Inc. AWA Astaware Technologies Inc. BPD Beau Pre Explorations Ltd. BDM Blue Diamond Mining Corporation COT Conac Software Corporation CGW Consolidated Gold Win Ventures Inc. COD.S GATCO Technologies Inc. GEI Green Environmental Technologies Inc. IND Indico Technologies Limited PE Plasma Environmental Technologies Inc. PFX Prefco Enterprises Inc. SSM Sourcesmith Industries Inc. SYN Syner-Seis Technologies Inc. TCH.U Touchstone Resources Ltd. UTO.B Uniglobe.com Inc. ______________________________________ ___________________________________________________________________ (c) Market News Publishing Inc. Tel:(604) 689-1101 All rights reserved. Fax:(604) 689-1106 MarketbyFax(tm) - To get the NEWS as it happens, call (604) 689-3041. VS20040503+2+000547
Bullboard Posts